Patents by Inventor Samantha Lien

Samantha Lien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IGF BINDING PROTEINS
    Publication number: 20080199886
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Application
    Filed: January 24, 2008
    Publication date: August 21, 2008
    Inventors: Henry Lowman, Samantha Lien
  • IGF binding proteins
    Patent number: 7351545
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: April 1, 2008
    Assignee: Genentech, Inc.
    Inventors: Henry Lowman, Samantha Lien
  • IGF binding proteins
    Patent number: 7348154
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: March 25, 2008
    Assignee: Genentech, Inc.
    Inventors: Henry Lowman, Samantha Lien
  • IGF binding proteins
    Patent number: 7192738
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: March 20, 2007
    Assignee: Genentech, Inc.
    Inventors: Henry Lowman, Samantha Lien
  • IGF binding proteins
    Publication number: 20070020698
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: January 25, 2007
    Inventors: Henry Lowman, Samantha Lien
  • IGF binding proteins
    Publication number: 20070020709
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: January 25, 2007
    Inventors: Henry Lowman, Samantha Lien
  • Polypeptide variants with altered effector function
    Publication number: 20060067930
    Abstract: The invention provides polypeptides having IgG Fc regions with amino acid modifications that result in the polypeptides exhibiting altered Fc effector functions.
    Type: Application
    Filed: August 19, 2005
    Publication date: March 30, 2006
    Applicant: Genentech, Inc.
    Inventors: Camellia Adams, Samantha Lien, Henry Lowman, Jonathan Marvin, Yu-Ju Meng
  • IGF binding proteins
    Publication number: 20050148035
    Abstract: IGFBP-3 fusion proteins are provided that are useful, for example, in cell-based assays, as IGF antagonists, and in mapping IGF-I and IGF-II binding sites on other molecules such as wild-type IGFBP-3 and IGF agonist peptides identified by phage display. Methods for making such fusion proteins are also provided.
    Type: Application
    Filed: September 8, 2004
    Publication date: July 7, 2005
    Inventors: Henry Lowman, Samantha Lien